Year: 2018
Type: article
Source: Nature Methods
Institutions: Massachusetts General Hospital, Center for Cancer Research, Center for Computational and Integrative Biology, Massachusetts General Hospital, Massachusetts Institute of Technology, Broad Institute, Harvard University, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Howard Hughes Medical Institute, Dana-Farber/Harvard Cancer Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funders: Burroughs Wellcome Fund, Doris Duke Charitable Foundation, Massachusetts General Hospital, National Institutes of Health, Defense Advanced Research Projects Agency, Society of Fellows, Harvard University, Advanced Research Projects Agency, RIKEN, National Heart, Lung, and Blood Institute, National Human Genome Research Institute, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: G1070450565, Systematic mapping and prediction of gene-enhancer connections, Discovering disease-causal variants by linking genetic and epigenetic variation, Mapping enhancer-gene regulation in single cells to connect genetic variants to target genes and cell types, High-throughput discovery of essential noncoding sequences for erythropoiesis, DEVELOPMENTAL BIOLOGY OF HUMAN ERYTHROPOIESIS, G4175877162, Identification of sequences and factors required for HbF repression, Identification of Novel Regulators of Fetal Hemoglobin Expression, Evolution, Optimization, and Application of Genome Editing Technologies, Epigenetic regulation of BCL11A in the hemoglobin switch, Systematic mapping and prediction of gene-enhancer connections, G7349955655, G7763705010, G9000327854, Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease
OpenAlex ID: W2949259699